PET detection of epidermal growth factor receptor in colorectal cancer: a real predictor of response to cetuximab treatment?
Pantaleo
M A
MA
Fanti
S
S
Lollini
P L
PL
Boschi
S
S
Biasco
G
G
D000911:Antibodies, Monoclonal / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D045744:Cell Line, Tumor; D000068818:Cetuximab; D015179:Colorectal Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy* / Q000378:metabolism; D003301:Copper Radioisotopes / Q000627:therapeutic use*; D066246:ErbB Receptors / Q000096:biosynthesis*; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D009362:Neoplasm Metastasis; D009368:Neoplasm Transplantation; D049268:Positron-Emission Tomography / Q000295:instrumentation / Q000379:methods*; D011874:Radiometry
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D003301:Copper Radioisotopes; D066246:ErbB Receptors; D000068818:Cetuximab